Rankings
▼
Calendar
ALT
Altimmune, Inc.
$331M
Q1 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$1M
Gross Profit
-$56,924
-5.7% margin
Operating Income
-$1M
-124.7% margin
Net Income
-$1M
-122.0% margin
EPS (Diluted)
$-5.72
QoQ Revenue Growth
-20.6%
Cash Flow
Operating Cash Flow
-$1M
Free Cash Flow
-$1M
Stock-Based Comp.
$181,921
Balance Sheet
Total Assets
$19M
Total Liabilities
$3M
Stockholders' Equity
$16M
Cash & Equivalents
$14M
← FY 2016
All Quarters
Q2 2016 →
ALT Q1 2016 Earnings — Altimmune, Inc. Revenue & Financial Results | Market Cap Arena
